---
figid: PMC4086482__nihms-599827-f0001
figtitle: Phosphoinositide-3-kinase-Akt-mTOR pathway
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4086482
filename: nihms-599827-f0001.jpg
figlink: /pmc/articles/PMC4086482/figure/F1/
number: F1
caption: The phosphoinositide-3-kinase-Akt-mTOR pathway. Green arrows indicate activation
  or positive regulation, red bars indicate inhibition. Red lightning bolts indicate
  genes frequently mutated in human breast cancers. Blue rectangles depict drugs either
  approved or being evaluated in clinical trials for breast cancer, and the targets
  they inhibit (black bars). For simplicity, other targets of Akt are not shown. P,
  phosphorylation; RTK, receptor tyrosine kinase.
papertitle: The Phosphoinositide-3-Kinase-Akt-mTOR Pathway as a Therapeutic Target
  in Breast Cancer.
reftext: Josh Lauring, et al. J Natl Compr Canc Netw. ;11(6):670-678.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9635947
figid_alias: PMC4086482__F1
figtype: Figure
redirect_from: /figures/PMC4086482__F1
ndex: c5e3a4e5-dec7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4086482__nihms-599827-f0001.html
  '@type': Dataset
  description: The phosphoinositide-3-kinase-Akt-mTOR pathway. Green arrows indicate
    activation or positive regulation, red bars indicate inhibition. Red lightning
    bolts indicate genes frequently mutated in human breast cancers. Blue rectangles
    depict drugs either approved or being evaluated in clinical trials for breast
    cancer, and the targets they inhibit (black bars). For simplicity, other targets
    of Akt are not shown. P, phosphorylation; RTK, receptor tyrosine kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Pdk1
  - Pdpk1
  - Pten
  - Mtor
  - Akt1
  - Ecm1
  - Ppp1r13b
  - Pik3r1
  - Tsc1
  - Tsc2
  - Rheb
  - Eif4e
  - Rps6kb1
  - Aaas
  - KRAS
  - HRAS
  - NRAS
  - PDK1
  - PDPK1
  - PTEN
  - MTOR
  - AKT1
  - AKT2
  - AKT3
  - MAPKAP1
  - RICTOR
  - MLST8
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - TSC1
  - CCL26
  - TSC2
  - RHEB
  - RHEBP1
  - EIF4E
  - EIF4E2
  - EIF4E3
  - RPS6KB1
  - DLX4
  - EIF4EBP1
  - RPTOR
  - APP
  - AAAS
  - AAA1
  - Tie
  - Ras85D
  - InR
  - Ras64B
  - Tor
  - Akt
  - Myb
  - Pi3K21B
  - Taf5
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - CycE
  - cyc
  - gig
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - S6k
  - Crtc
  - tRNA:Lys-TTT-1-1
  - tRNA:Lys-TTT-2-4
  - tRNA:Lys-TTT-2-1
  - tRNA:Lys-TTT-2-2
  - tRNA:Lys-TTT-2-5
  - tRNA:Lys-TTT-2-3
  - Temsirolimus
  - Ridaforolimus
  - BEZ235
  - GDC-0980
  - Glucose
  - Cancer
---
